Keyphrases
Clinical Features
100%
Rheumatoid Arthritis
100%
Medication Use
100%
Sectional Analysis
100%
Systemic Juvenile Idiopathic Arthritis (sJIA)
100%
Tumour Necrosis Factor Inhibitor (TNFi)
57%
Methotrexate
28%
Classification Criteria
28%
Well-defined
14%
Rheumatoid Arthritis Patients
14%
Rheumatoid Factor
14%
Adulthood
14%
Improved Outcomes
14%
Clinical Characteristics
14%
McNemar Test
14%
Etanercept
14%
Rheumatology Clinic
14%
American College of Rheumatology
14%
Long Disease Duration
14%
Rheumatology Practice
14%
Arthritis Patients
14%
Mislabeling
14%
Anti-cyclic Citrullinated Peptide Antibody (anti-CCP)
14%
Accelerated Failure Time Model
14%
Persistent Disease
14%
European League against Rheumatism (EULAR)
14%
Unique Populations
14%
Medicine and Dentistry
Clinical Feature
100%
Cross Sectional Study
100%
Rheumatoid Arthritis
100%
Juvenile Idiopathic Arthritis
100%
TNF Inhibitor
50%
Rheumatology
37%
Methotrexate
25%
Prevalence
12%
Disease Duration
12%
McNemar Test
12%
Etanercept
12%
Rheumatoid Factor
12%
Rheumatic Disease
12%
Diseases
12%
Nursing and Health Professions
Clinical Feature
100%
Juvenile Rheumatoid Arthritis
100%
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Tumor Necrosis Factor Inhibitor
50%
Methotrexate
25%
Hospital
12%
Prevalence
12%
Cross-Sectional Study
12%
McNemar Test
12%
Rheumatoid Factor
12%
Etanercept
12%
Disease Duration
12%
Rheumatic Disease
12%
Diseases
12%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Clinical Feature
100%
Cross Sectional Study
100%
Juvenile Rheumatoid Arthritis
100%
Tumor Necrosis Factor Inhibitor
50%
Methotrexate
25%
Prevalence
12%
Cross-Sectional Study
12%
Etanercept
12%
Rheumatoid Factor
12%
Rheumatic Disease
12%
Disease Duration
12%
Diseases
12%